Glaucoma shunts with flow management and improved surgical performance

• US 8,702,639 B2
• Filed: 03/25/2010
• Issued: 04/22/2014
• Est. Priority Date: 03/26/2009
• Status: Active Grant

• Current Assignee: Johnson & Johnson Surgical Vision, Inc. (Johnson & Johnson)
• Original Assignee: Abbott Medical Optics Incorporated (Johnson & Johnson)
• Inventors: Van Der Mooren, Marrie H., Bogaert, Theophilus, Jain, Rakhi
• Primary Examiner(s): HAND, MELANIE JO
• Application Number:
  US12/732,030
• Publication Number:
  US 20100249691A1
• Time in Patent Office: 1,489 Days
• Field of Search: 604 8- 10, 604/264, 604/294, 606 4- 6
• US Class Current: 604/8
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002

Abstract

A method of treating glaucoma in an eye by managing fluid flow past an implanted shunt having an elastomeric plate and a non-valved elastomeric drainage tube. The plate is positioned over a sclera of the eye with an outflow end of the elastomeric drainage tube open to an outer face of the plate. An inflow end of the drainage tube tunnels through the sclera to the anterior chamber of the eye. The plate may have regions of greater propensity for cell adhesion alternating with regions of lesser cell adhesion. For example, regions of texturing around the plate or drainage tube may be provided to control the size of a bleb that forms over the implant. The effective surface area of the plate may be balanced against a number of fenestrations. The drainage tube has a reduced profile and may be shaped with a non-circular external cross-section to reduce its height. A scleral groove may be used to further reduce the height of the drainage tube on the sclera. A flow restrictor for the early post operative period will immediately lower the intraocular pressure (IOP) and simultaneously prevent hypotony.

Claims

1. An implantable glaucoma shunt for treating glaucoma in an eye, comprising:

a plate adapted to be positioned on the sclera and having an effective surface area A_eff of 250 mm² or less, the plate also having at least 8 fenestrations extending between an outer face and an inner face; and

an elastomeric drainage tube having an outflow end connected to the plate and opening at the outer face thereof, and an inflow end extending away from the plate, the drainage tube having an open lumen and a length sufficient to extend into the anterior chamber of the eye,

wherein the plate has microtexturing on at least an outer or an inner face comprising an average peak-to-valley depth normal to the outer face of between about 0.5-10 microns.

2. The glaucoma shunt of claim 1, wherein the effective surface area of the plate (A_eff) is determined by the formula A_eff=A+G, where:

A=the tissue area surrounding the plate being around 200-400 mm², and

G=a reduction in effective plate surface area determined by;

G=M(π

R²)−

M(2π

RB)

where;

M=number of fenestration holes,

R=radius of fenestration holes, and

B=bleb height.

3. The glaucoma shunt of claim 1, wherein both the inner and outer faces have the microtexturing, and the microtexturing is provided in different patterns on the inner and outer faces.

4. The glaucoma shunt of claim 1, wherein the microtexturing is further provided on the exterior of the elastomeric drainage tube.

5. The glaucoma shunt of claim 1, wherein the drainage tube has a coating of antimicrobial material within its lumen.

6. The glaucoma shunt of claim 1, further including a flow restrictor positioned within the drainage tube having an open throughbore smaller than the lumen.

7. The glaucoma shunt of claim 1, further including a flow restrictor positioned within the drainage tube and being movable therein, the flow restrictor having exterior length markings and a length sufficient to extend from within the drainage tube to a location past a bleb that forms over the plate after implant.

8. An implantable glaucoma shunt for treating glaucoma in an eye, comprising:

a plate adapted to be positioned on the sclera; and

an elastomeric drainage tube having an outflow end connected to the plate and opening at the outer face thereof, and an inflow end extending away from the plate, the drainage tube having an open lumen and a length sufficient to extend into the anterior chamber of the eye, the inner lumen of the tube having a radius of less than 50 microns.

9. The glaucoma shunt of claim 8, wherein the inner tube lumen radius is less than 50 microns and greater than or equal to a magnitude determined by the following formula:

r=(8η

L/π

R)^0.25

where;

average aqueous resistance R=3.333 mmHg/microliter/minute,

1 mmHg=133.3 Pa (kgm/s²),

1 microliter/minute=1,667×

10<sup>−

11</sup> m³/s,

L=length of tube (mm),

average aqueous resistance R=2.666×

10¹³ kg/sm², and

dynamic viscosity h=7.50×

10<sup>−

4</sup> kg/sm.

10. The glaucoma shunt of claim 8, wherein the plate has microtexturing on at least an outer or an inner face comprising an average peak-to-valley depth normal to the outer face of between about 0.5-10 microns.

11. The glaucoma shunt of claim 10, wherein both the inner and outer faces have the microtexturing, and the microtexturing is provided in different patterns on the inner and outer faces.

12. The glaucoma shunt of claim 10, wherein the microtexturing is further provided on the exterior of the elastomeric drainage tube.

13. The glaucoma shunt of claim 8, wherein the drainage tube has a coating of antimicrobial material within its lumen.

14. The glaucoma shunt of claim 8, further including a flow restrictor positioned within the drainage tube having an open throughbore smaller than the lumen.

15. The glaucoma shunt of claim 8, further including a flow restrictor positioned within the drainage tube and being movable therein, the flow restrictor having exterior length markings and a length sufficient to extend from within the drainage tube to a location past a bleb that forms over the plate after implant.